Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Immunogen Inc. | 4 | 0 | 0 | 0 | €28.97 | - | - |
| Incyte Corp. | 12 | 2 | 2 | 0 | €52.70 | €78.42 | 48.809% |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €14.20 | €30.00 | 111.268% |
| Insmed Inc. | 27 | 2 | 14 | 2 | €46.80 | €50.69 | 8.319% |
| Intra-Cellular Therapies Inc. | 25 | 0 | 2 | 0 | €62.00 | €79.55 | 28.313% |
| Iovance Biotherapeutics Inc. | 21 | 3 | 2 | 0 | €8.60 | €25.20 | 193.192% |
| Kala Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €5.62 | €19.50 | 246.948% |
| Krystal Biotech | 18 | 0 | 2 | 0 | €146.35 | €179.60 | 22.716% |
| Lexicon Pharmaceuticals Inc. | 2 | 0 | 1 | 0 | €1.52 | €5.34 | 250.361% |
| MacroGenics Inc. | 13 | 0 | 4 | 0 | €3.84 | €12.42 | 223.729% |
| MannKind Corp. | 8 | 0 | 1 | 0 | €4.20 | €6.03 | 43.546% |
| Medpace Holdings Inc | 11 | 0 | 2 | 0 | €358.90 | €419.64 | 16.923% |
| Merck & Co. Inc. | 28 | 1 | 0 | 0 | €116.60 | €124.92 | 7.137% |
| Natural Alternat. | 19 | 1 | 2 | 0 | €5.95 | - | - |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.27 | €3.70 | 190.652% |
| Neurocrine Bioscience | 31 | 0 | 8 | 0 | €124.65 | €140.60 | 12.799% |
| Novavax Inc. | 8 | 1 | 6 | 0 | €13.99 | €27.38 | 95.771% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €20.39 | - | - |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €26.60 | €47.53 | 78.677% |
| Pfizer Inc. | 27 | 4 | 1 | 0 | €25.77 | €40.66 | 57.778% |
| Phibro Animal Health Corp. A | 4 | 2 | 0 | 1 | €16.40 | €12.06 | -26.439% |
| Precision BioSciences Inc | 8 | 0 | 2 | 0 | €0.35 | €3.00 | 762.069% |
| PTC Therapeutics Inc. | 15 | 8 | 3 | 3 | €31.80 | €41.51 | 30.542% |
| Regeneron Pharmaceuticals Inc. | 36 | 1 | 3 | 0 | €895.40 | €958.32 | 7.027% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €144.35 | €184.76 | 27.994% |